バーチャル臨床試験市場規模、シェア、成長分析、試験デザイン別、タイプ別、フェーズ別、適応症別、産業別、地域別- 産業予測、2025-2032年

バーチャル臨床試験（VCT）の世界市場規模は、2023年に93億米ドルと評価され、2024年の99億米ドルから2032年には162億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは6.4％で成長する見通しです。

世界のヘルスケア市場は、主にヘルスケアインフラのデジタル化の加速により、著しい成長を遂げています。皮膚科検査におけるバーチャル臨床試験の採用が増加していることが、この成長をさらに後押ししています。これらの検査は、複雑な検査を必要としない皮膚状態の評価を容易にするためです。COVID-19の流行は、安全なバーチャル検査ソリューションへの需要を高め、効果的なデータ収集を促進しています。さらに、仮想患者対話プラットフォームやウェアラブルデバイスの登場などの技術的進歩により、遠隔医療を通じた患者と医師のつながりが強化されています。しかし、標準化されたガイドラインの欠如や、溢れかえる情報を効果的に管理する必要性から、市場の拡大は課題に直面する可能性があります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

バーチャル臨床試験市場規模：試験デザイン

• 市場概要
• 介入的
• 観察的
• 拡大アクセス

バーチャル臨床試験市場規模：タイプ別

• 市場概要
• 完全バーチャルトライアル
• ハイブリッドバーチャルトライアル

バーチャル臨床試験市場規模：フェーズ別

• 市場概要
• フェーズI
• フェーズII
• フェーズIII
• フェーズIV

バーチャル臨床試験市場規模：適応症別

• 市場概要
• 中枢神経系
• 自己免疫/炎症
• 心血管疾患
• 代謝・内分泌学
• 感染症
• 腫瘍学
• 泌尿生殖器
• 眼科
• その他の適応症

バーチャル臨床試験市場規模：産業別

• 市場概要
• 製薬・バイオテクノロジー企業
• 受託調査機関（CRO）
• 医療機器企業
• その他の産業

バーチャル臨床試験市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• IQVIA（USA）
• ICON plc（Ireland）
• Parexel International（USA）
• Charles River Laboratories（USA）
• Medidata Solutions（USA）
• Oracle Health（USA）
• PRA Health Sciences（USA）
• Pharmaleads（USA）
• Medpace（USA）
• Certara（USA）
• Syntract（USA）
• Velocity Clinical Research（USA）
• INC Research（USA）

結論と提言

Global Virtual Clinical Trials Market size was valued at USD 9.3 billion in 2023 and is poised to grow from USD 9.9 billion in 2024 to USD 16.25 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).

The global healthcare market is witnessing significant growth, primarily due to the accelerated digitization of healthcare infrastructure. The rising adoption of virtual clinical trials (VCT) for dermatological testing is further propelling this growth, as these trials facilitate the evaluation of skin conditions that do not involve intricate examinations. The COVID-19 pandemic has intensified the demand for safe virtual testing solutions, fostering effective data collection. Additionally, technological advancements, including the advent of virtual patient interaction platforms and wearable devices, are enhancing patient-clinician connectivity through telemedicine. However, market expansion may face challenges due to a lack of standardized guidelines and the necessity to manage the overwhelming influx of information effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Virtual Clinical Trials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Virtual Clinical Trials Market Segments Analysis

Global Virtual Clinical Trials Market is segmented by Study Design, Type, Phases, Indication, Industry and region. Based on Study Design, the market is segmented into Interventional, Observational and Expanded access. Based on Type, the market is segmented into Fully virtual trials and Hybrid virtual trials. Based on Phases, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on Indication, the market is segmented into CNS, Autoimmune/inflammation, Cardiovascular disease, Metabolic/endocrinology, Infectious disease, Oncology, Genitourinary, Ophthalmology and Other indications. Based on Industry, the market is segmented into Pharmaceutical and biotechnology companies, Contract research organizations (CROs), Medical devices companies and Other industries. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Virtual Clinical Trials Market

One of the key drivers fueling the expansion of the Global Virtual Clinical Trials market is the advancement in real-time reporting and data collection. This innovative approach enables researchers to gather and analyze data instantaneously, enhancing the efficiency and accuracy of clinical trials. The ability to monitor participant responses and treatment effects in real time allows for more informed decision-making and timely adjustments to trial protocols. As a result, this capability not only accelerates the drug development process but also improves participant engagement and adherence. Consequently, the demand for virtual clinical trials is on the rise, transforming the landscape of clinical research.

Restraints in the Global Virtual Clinical Trials Market

One significant challenge facing the Global Virtual Clinical Trials market is the apprehension regarding data accuracy and security. As virtual trials heavily rely on the collection and management of sensitive patient information, concerns about the potential for data breaches and inaccuracies can hinder stakeholder confidence. The reliance on digital platforms increases the risk of unauthorized access to confidential data, leading to possible violations of privacy and regulatory standards. Consequently, these concerns may dissuade participation from patients and researchers alike, ultimately impacting the overall effectiveness and trustworthiness of virtual clinical trials in the healthcare landscape.

Market Trends of the Global Virtual Clinical Trials Market

The Global Virtual Clinical Trials market is poised for significant growth, driven by the increasing adoption of connected devices and innovative digital tools such as eCOA, ePRO, and eConsent. This shift towards a remote, participant-centric model is evidenced by the widespread acceptance of the bring-your-own-device strategy among Contract Research Organizations (CROs) and sponsors, enhancing data collection and analysis. Additionally, advancements in artificial intelligence are revolutionizing trial processes, expediting target validation and patient recruitment. The emergence of synthetic clinical trial methodologies further exemplifies the evolving landscape, positioning virtual trials as a viable and efficient alternative to traditional methods.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Virtual Clinical Trials Market Size by Study Design & CAGR (2025-2032)

• Market Overview
• Interventional
• Observational
• Expanded access

Global Virtual Clinical Trials Market Size by Type & CAGR (2025-2032)

• Market Overview
• Fully virtual trials
• Hybrid virtual trials

Global Virtual Clinical Trials Market Size by Phases & CAGR (2025-2032)

• Market Overview
• Phase I
• Phase II
• Phase III
• Phase IV

Global Virtual Clinical Trials Market Size by Indication & CAGR (2025-2032)

• Market Overview
• CNS
• Autoimmune/inflammation
• Cardiovascular disease
• Metabolic/endocrinology
• Infectious disease
• Oncology
• Genitourinary
• Ophthalmology
• Other indications

Global Virtual Clinical Trials Market Size by Industry & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and biotechnology companies
• Contract research organizations (CROs)
• Medical devices companies
• Other industries

Global Virtual Clinical Trials Market Size & CAGR (2025-2032)

• North America (Study Design, Type, Phases, Indication, Industry)
  • US
  • Canada
• Europe (Study Design, Type, Phases, Indication, Industry)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Study Design, Type, Phases, Indication, Industry)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Study Design, Type, Phases, Indication, Industry)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Study Design, Type, Phases, Indication, Industry)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IQVIA (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medidata Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PRA Health Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaleads (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syntract (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Velocity Clinical Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• INC Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations